13D/13G Filings - BioAge Labs Inc. (BIOA)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-02-14
6:27 pm
Sale
2024-12-31 13G BioAge Labs, Inc.
BIOA
RA Capital Management, L.P. 1,310,589
3.700%
-900,000decrease
(-40.71%)
Filing
History
2025-02-14
3:00 pm
Purchase
2024-12-31 13G BioAge Labs, Inc.
BIOA
Cormorant Asset Management LP 2,629,529
7.340%
2,629,529increase
(New Position)
Filing
History
2024-11-14
4:15 pm
Purchase
2024-09-30 13G BioAge Labs, Inc.
BIOA
Khosla Ventures VI L.P. 1,798,702
5.000%
1,798,702increase
(New Position)
Filing
History
2024-11-12
4:15 pm
Purchase
2024-09-30 13G BioAge Labs, Inc.
BIOA
Fortney Kristen 2,331,072
6.600%
2,331,072increase
(New Position)
Filing
History
2024-10-07
4:16 pm
Purchase
2024-09-27 13G BioAge Labs, Inc.
BIOA
RA Capital Management, L.P. 2,210,589
6.200%
2,210,589increase
(New Position)
Filing
History
2024-10-04
8:21 pm
Purchase
2024-09-27 13D BioAge Labs, Inc.
BIOA
AH Bio Fund I L.P. 3,233,170
9.000%
3,233,170increase
(New Position)
Filing
History
2024-09-30
8:34 pm
Purchase
2024-09-27 13D BIOAMBER INC,
BIOAQ
Sofinnova Venture Partners XI L.P. 2,304,901
6.700%
2,304,901increase
(New Position)
Filing
History